Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy.
Singh A, Mencia-Trinchant N, Griffiths EA, Altahan A, Swaminathan M, Gupta M, Gravina M, Tajammal R, Faber MG, Yan L, Sinha E, Hassane DC, Hayes DN, Guzman ML, Iyer R, Wang ES, Thota S.
Singh A, et al. Among authors: gravina m.
JCO Precis Oncol. 2022 Jan;6:e2100309. doi: 10.1200/PO.21.00309.
JCO Precis Oncol. 2022.
PMID: 35025619
Free PMC article.